SELPERCATINIB for Thyroid cancer metastatic: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 15 adverse event reports in the FDA FAERS database where SELPERCATINIB was used for Thyroid cancer metastatic.
Most Reported Side Effects for SELPERCATINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Malignant neoplasm progression | 106 | 9.8% | 31 | 32 |
| Death | 90 | 8.3% | 88 | 1 |
| Hypertension | 58 | 5.4% | 1 | 18 |
| Hypersensitivity | 55 | 5.1% | 4 | 34 |
| Diarrhoea | 54 | 5.0% | 10 | 19 |
| Fatigue | 51 | 4.7% | 2 | 16 |
| Rash | 49 | 4.5% | 2 | 17 |
| Hepatic function abnormal | 42 | 3.9% | 3 | 21 |
| Alanine aminotransferase increased | 38 | 3.5% | 4 | 19 |
| Pyrexia | 38 | 3.5% | 1 | 18 |
| Aspartate aminotransferase increased | 37 | 3.4% | 4 | 17 |
| Ascites | 33 | 3.0% | 3 | 7 |
| Dry mouth | 32 | 3.0% | 5 | 10 |
| Electrocardiogram qt prolonged | 32 | 3.0% | 1 | 18 |
| Thrombocytopenia | 31 | 2.9% | 5 | 16 |
Other Indications for SELPERCATINIB
Non-small cell lung cancer (231)
Product used for unknown indication (214)
Lung neoplasm malignant (158)
Medullary thyroid cancer (116)
Thyroid cancer (59)
Lung adenocarcinoma (50)
Non-small cell lung cancer stage iv (23)
Lung adenocarcinoma stage iv (20)
Lung carcinoma cell type unspecified stage 0 (19)
Non-small cell lung cancer metastatic (18)
Other Drugs Used for Thyroid cancer metastatic
LENVATINIB (137)
CABOZANTINIB S-MALATE (90)
SORAFENIB (81)
DABRAFENIB (25)
VANDETANIB (20)
PEMBROLIZUMAB (18)
PRALSETINIB (17)
TRAMETINIB DIMETHYL SULFOXIDE (17)
ENCORAFENIB (16)
BINIMETINIB (15)